<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03109496</url>
  </required_header>
  <id_info>
    <org_study_id>B300201731724</org_study_id>
    <nct_id>NCT03109496</nct_id>
  </id_info>
  <brief_title>The URT and Middle Ear Microbiota in Health and During Chronic OME</brief_title>
  <official_title>Study of the Upper Respiratory Tract Microbiota and the Potential of Probiotics for the Treatment of Chronic Otitis Media With Effusion.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study analyses which bacteria are present in the middle ear space and adjacent upper
      respiratory tract niches in healthy people and in patients suffering from chronic otitis
      media with effusion (OME; glue ear). The aim is to identify and isolate bacteria that are
      more common and more abundant in healthy people and to evaluate their potential to protect
      against bacteria commonly involved in OME and other upper respiratory tract infections.

      To this end, samples will be collected from both groups (healthy vs OME) and analysed through
      sequencing of the bacterial 16S gene. In addition, samples obtained from healthy participants
      will be cultivated to isolate bacteria of interest.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 26, 2017</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Microbiota differences between the healthy and diseased URT and middle ear space</measure>
    <time_frame>Appr. 4 years</time_frame>
    <description>The composition of the bacterial community will be determined through sequencing of the bacterial 16S gene and compared between the participant groups. Species over-represented in healthy participants will be investigated further.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Otitis Media With Effusion</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>OME Patients</arm_group_label>
    <description>Suffer from chronic Otitis Media with Effusion (OME) for at least 3 months and undergo ventilation tube placement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <description>Undergo surgery that gives access to the middle ear space (e.g. cochlear implant surgery) or adenoids, in absence of upper respiratory tract infections.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Collection of body fluids/swabs</intervention_name>
    <description>Middle ear, ear duct, anterior nare, nasopharynx, adenoids. Niches depend on accessibility for each individual participant.</description>
    <arm_group_label>OME Patients</arm_group_label>
    <arm_group_label>Healthy Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        100 healthy participants vs 100 OME patients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Controls: undergo a surgery that gives access to the middle ear space (at least 30
             participants; e.g. cochlear implant recipients) or the adenoids.

          -  OME patients: have fluid accumulation in the middle ear space for 3+ months and
             receive ventilation tubes. May also undergo adenoidectomy.

        Exclusion Criteria:

          -  Acute upper respiratory tract infections (including acute otitis media)

          -  Chronic upper respiratory tract infections (except OME in patient group)

          -  URT malformations (e.g. as seen in people with Down Syndrome or cleft palate)

          -  Cystic fibrosis

          -  Autoimmune diseases or immunodeficiency

          -  Pregnancy

          -  Use of antibiotics or steroids 1 week before surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Antwerp University Hospital</name>
      <address>
        <city>Edegem</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier M Vanderveken, MD, PhD</last_name>
      <phone>+ 32 3 821 33 84</phone>
      <email>Olivier.Vanderveken@uza.be</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Jörissen, MSc</last_name>
      <phone>+32 3 265 3217</phone>
      <email>jennifer.jorissen@uantwerpen.be</email>
    </contact_backup>
    <investigator>
      <last_name>Olivier M Vanderveken, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2017</study_first_submitted>
  <study_first_submitted_qc>April 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>December 21, 2017</last_update_submitted>
  <last_update_submitted_qc>December 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Antwerp</investigator_affiliation>
    <investigator_full_name>Ethisch Comité UZA</investigator_full_name>
    <investigator_title>prof. dr. Olivier Vanderveken, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>OME</keyword>
  <keyword>Otitis Media with Effusion</keyword>
  <keyword>Microbiota</keyword>
  <keyword>Microbiome</keyword>
  <keyword>URT</keyword>
  <keyword>Upper Respiratory Tract</keyword>
  <keyword>Healthy URT microbiota</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
    <mesh_term>Otitis Media with Effusion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

